InfuSystem Holdings, Inc. raised earnings guidance for the full year 2023. For the period, the company's net revenue growth estimated to be above 11%, up from its previous estimate calling for an annual growth rate above 10%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.62 USD | -6.16% | -1.55% | -27.70% |
Apr. 10 | Gregg Lehman Not to Stand for Re-Election as Director of InfuSystem Holdings, Inc | CI |
Mar. 14 | Transcript : InfuSystem Holdings, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.70% | 162M | |
-2.54% | 186B | |
-1.85% | 107B | |
-4.26% | 67.44B | |
+1.39% | 50.03B | |
+16.82% | 47.81B | |
+4.31% | 41.03B | |
+3.49% | 26.85B | |
+0.65% | 25.82B | |
+16.42% | 24.74B |
- Stock Market
- Equities
- INFU Stock
- News InfuSystem Holdings, Inc.
- InfuSystem Holdings, Inc. Raises Earnings Guidance for the Full Year 2023